Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models

Neurosci Lett. 2011 Jan 3;487(1):94-8. doi: 10.1016/j.neulet.2010.09.079. Epub 2010 Oct 8.

Abstract

A mouse and human brain-enriched micro-RNA-146a (miRNA-146a) is known to be important in modulating the innate immune response and inflammatory signaling in certain immunological and brain cell types. In this study we examined miRNA-146a levels in early-, moderate- and late-stage Alzheimer's disease (AD) neocortex and hippocampus, in several human primary brain and retinal cell lines, and in 5 different transgenic mouse models of AD including Tg2576, TgCRND8, PSAPP, 3xTg-AD and 5xFAD. Inducible expression of miRNA-146a was found to be significantly up-regulated in a primary co-culture of human neuronal-glial (HNG) cells stressed using interleukin1-beta (IL-1β), and this up-regulation was quenched using specific NF-кB inhibitors including curcumin. Expression of miRNA-146a correlated with senile plaque density and synaptic pathology in Tg2576 and in 5xFAD transgenic mouse models used in the study of this common neurodegenerative disorder.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Amyloid beta-Protein Precursor / genetics
  • Animals
  • Cell Line, Transformed
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • Hippocampus / metabolism*
  • Humans
  • Mice
  • Mice, Transgenic
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Mutation
  • Neocortex / metabolism*
  • Presenilin-1 / genetics
  • Transfection / methods
  • Up-Regulation / drug effects
  • Up-Regulation / genetics*
  • tau Proteins / genetics

Substances

  • Amyloid beta-Protein Precursor
  • Enzyme Inhibitors
  • MIRN146 microRNA, human
  • MicroRNAs
  • PSEN1 protein, human
  • Presenilin-1
  • tau Proteins